Summit X, LLC Iveric Bio, Inc. Transaction History

Summit X, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$12.15 - $16.83 $137,902 - $191,020	-11,350 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$13.83 - $18.78 $20,745 - $28,170	-1,500 Reduced 11.67%	11,350 $188,000
Q3 2020 Nov 12, 2020	SELL	$4.01 - $6.29 $601 - $943	-150 Reduced 1.15%	12,850 $73,000
Q2 2020 Aug 13, 2020	SELL	$3.06 - $6.6 $6,120 - $13,200	-2,000 Reduced 13.33%	13,000 $66,000
Q1 2020 May 13, 2020	SELL	$2.83 - $8.44 $51,279 - $152,932	-18,120 Reduced 54.71%	15,000 $52,000
Q4 2019 Jan 23, 2020	SELL	$0.93 - $8.58 $54,213 - $500,162	-58,294 Reduced 63.77%	33,120 $285,000
Q3 2019 Oct 15, 2019	BUY	$1.09 - $1.29 $3,270 - $3,870	3,000 Added 3.39%	91,414 $100,000
Q2 2019 Aug 13, 2019	BUY	$1.21 - $1.48 $106,980 - $130,852	88,414 New	88,414 $119,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.